Effect of daily avocado consumption for 6 mo compared with habitual diet on red blood cell fatty acid profiles and association with cardiometabolic risk factors in individuals with abdominal obesity: a randomized trial.
Study Goal
The researchers aimed to determine whether daily avocado consumption affects red blood cell fatty acid composition and its association with visceral adiposity and cardiometabolic risk factors in individuals with abdominal obesity.
Results Summary
Daily avocado intake modified RBC-MUFA composition (notably 18:1n-7c) and potentially mitigated unfavorable associations between certain RBC fatty acids and cardiometabolic risk factors observed in the control group. No major differences in RBC-FA profiles were found between groups except for MUFA cis-vaccenic acid.
Population
Individuals with abdominal obesity (n = 994), with adjustments for age, sex, BMI, clinical site, smoking status, and fat intake.
Effective Dosage
1 avocado per day
Duration
6 months
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
consuming 1 avocado/d | increase | RBC-MUFA composition | individuals with abdominal obesity | - | modified | #1 |
consuming 1 avocado/d | increase | RBC-FA MUFA cis-vaccenic [18:1n-7c] | AVO participants | β: 0.11 [0.05, 0.17] | significantly higher | #2 |
habitual diet with limited avocado intake | no change | RBC-FA profiles | HAB participants | - | no major differences | #3 |
habitual diet with limited avocado intake | increase | RBC-FA MUFA cis (18:1n-7c, oleic [18;1n-9c], erucic [22:1n-9c]) | HAB group | - | increases | #4 |
habitual diet with limited avocado intake | increase | RBC-FA MUFA trans (palmitelaidic [16:1n-7t], vaccenic [18:1n-7t], elaidic [18:1n-9t], and petroselaidic [18;1n-10-12t) | HAB group | - | increases | #5 |
habitual diet with limited avocado intake | increase | RBC-FA PUFA γ-linolenic [18:3n-6], dihomo-γ-linolenic [20:3n-6], arachidonic [20:4n-6], and α-linolenic [18:3n-3] | HAB group | - | increases | #6 |
habitual diet with limited avocado intake | increase | visceral adiposity measures | HAB group | - | associated with unfavorable changes | #7 |
habitual diet with limited avocado intake | increase | lipid profiles | HAB group | - | associated with unfavorable changes | #8 |
habitual diet with limited avocado intake | increase | glucose concentrations | HAB group | - | associated with unfavorable changes | #9 |
habitual diet with limited avocado intake | increase | insulin concentrations | HAB group | - | associated with unfavorable changes | #10 |
habitual diet with limited avocado intake | increase | high sensitivity C-reactive protein concentrations | HAB group | - | associated with unfavorable changes | #11 |
daily avocado intake over 6-mo | decrease | unfavorable individual RBC-FA-CMRF associations | AVO group | - | potentially mitigated | #12 |
BACKGROUND: Avocado intake improves dietary fat quality, but the subsequent impact on red blood cell (RBC) saturated (SFA), monounsaturated (MUFA), polyunsaturated (PUFA), and trans-fatty acid (TFA) composition and association with cardiometabolic health, has not been elucidated. OBJECTIVES: To compare the effect of consuming 1 avocado/d relative to habitual diet (HAB) on RBC-FA profiles, and their association with visceral adiposity and cardiometabolic risk factors (CMRFs) in individuals with abdominal obesity. METHODS: RBC-FA profiling at baseline, 3- and 6 mo was conducted in participants (n = 994) from the Habitual Diet and Avocado Trial (HAT). HAT was a multisite, free-living, parallel-arm intervention study in which participants were randomly assigned to either the avocado-supplemented group (AVO, usual diet with 1 avocado/d) or the HAB group (usual diet with limited avocado intake) for 6 mo. Changes in RBC-FA profiles, a secondary outcome measure, were determined within and between groups using linear regression and mixed effect models, adjusting for age, sex, BMI, clinical site, smoking status, and percentage of energy intake from fat at baseline. The association between changes in RBC-FAs with visceral adiposity measures and CMRFs was assessed after covariate and False Discovery Rate (FDR <0.05) adjustment. RESULTS: No major differences in RBC-FA profiles were observed between groups, with the exception of MUFA cis-vaccenic [18:1n-7c], which was significantly higher in AVO (β: 0.11 [0.05, 0.17]) compared with the HAB (β: 0.03 [-0.03, 0.08]) participants. In the HAB but not AVO group, increases in MUFA cis (18:1n-7c, oleic [18;1n-9c], erucic [22:1n-9c]) and MUFA trans (palmitelaidic [16:1n-7t], vaccenic [18:1n-7t], elaidic [18:1n-9t], and petroselaidic [18;1n-10-12t), as well as PUFA γ-linolenic [18:3n-6], dihomo-γ-linolenic [20:3n-6], arachidonic [20:4n-6], and α-linolenic [18:3n-3] were associated with unfavorable changes in visceral adiposity measures, lipid profiles, glucose, insulin and high sensitivity C-reactive protein concentrations. CONCLUSIONS: Daily avocado intake over 6-mo modified RBC-MUFA composition, notably 18:1n-7c, and potentially mitigated some of the unfavorable individual RBC-FA-CMRF associations observed over time in the HAB group. This trial was registered at https://clinicaltrials.gov/study as NCT03528031.